Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes

NCT00837759 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

NIH

Sponsor class

Stopped Changes to study personnel.

Conditions

Diabetes Mellitus Type 1
Autoimmune Diabetes

Interventions

DRUG: Insulin
DRUG: Lansoprazole
DRUG: Sitagliptin
BIOLOGICAL: Diamyd
DRUG: GAD65 (Diamyd)

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)